Drug Type Small molecule drug |
Synonyms Erechrome, BAP-909, 恒扬 |
Target |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (20 May 2011), |
RegulationSpecial Review Project (CN) |
Molecular FormulaC21H23NO3S |
InChIKeyAXMZZGKKZDJGAZ-UHFFFAOYSA-N |
CAS Registry395683-14-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoarthritis | CN | 20 May 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatic Insufficiency | Phase 1 | CN | 03 Jan 2015 | |
Hepatic Insufficiency | Phase 1 | CN | 03 Jan 2015 | |
Osteoarthritis, Knee | Phase 1 | CN | 01 Jan 2015 | |
Renal Insufficiency | Phase 1 | CN | 25 May 2013 | |
Renal Insufficiency | Phase 1 | CN | 25 May 2013 |
Not Applicable | 120 | onbmjkimyp(vwlrntcppj) = zvcydcnbvs bnhtqyaxtq (ajijhiymqd ) View more | - | 14 Jun 2017 | |||
onbmjkimyp(vwlrntcppj) = soewkevckq bnhtqyaxtq (ajijhiymqd ) View more |